Valuation: The ACME Laboratories Ltd.

Market Cap 17.44B 141M 126M 117M 106M 198M 13.37B 200M 1.4B 555M 7.01B 528M 517M 22.22B P/E 2024
5.9x
P/E 2025 6.29x
Enterprise Value 40.31B 325M 292M 270M 245M 457M 30.91B 463M 3.23B 1.28B 16.2B 1.22B 1.2B 51.37B EV / Sales 2024
1.15x
EV / Sales 2025 1.06x
Free-Float
51.84%
Yield 2024
5.11%
Yield 2025 4.85%
1 day+0.52%
1 week+0.13%
Current month-0.90%
1 month-1.90%
3 months-6.17%
6 months+2.65%
Current year+9.31%
1 week 76.5
Extreme 76.5
78.4
1 month 76.2
Extreme 76.2
78.8
Current year 70.6
Extreme 70.6
88.7
1 year 68.6
Extreme 68.6
88.7
3 years 62.6
Extreme 62.6
94.5
5 years 62.6
Extreme 62.6
111
10 years 54.2
Extreme 54.2
122.4
Manager TitleAgeSince
Chief Executive Officer 82 30/09/1995
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 82 17/03/1975
Director/Board Member 76 14/04/1981
Chairman 69 04/09/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.52%+0.13%+2.92%-8.82% 132M
+0.22%-0.14%+55.12%+128.82% 1,143B
+0.91%+3.61%+41.21%+84.57% 647B
-0.12%-0.93%+25.59%+106.14% 506B
+0.63%+2.33%+49.21%+67.82% 384B
+0.86%-4.37%+61.16%+37.93% 350B
+1.02%+1.80%+24.84%+53.75% 293B
-0.25%+1.62%+2.20%+26.65% 265B
+0.75%+2.05%+53.85%+71.25% 242B
+0.25%+1.64%+32.05%+107.62% 197B
Average +0.48%+0.76%+34.82%+67.57% 402.77B
Weighted average by Cap. +0.44%+0.71%+42.24%+88.46%

Financials

2024 2025
Net sales 31.93B 258M 231M 214M 194M 362M 24.48B 366M 2.56B 1.02B 12.83B 968M 947M 40.7B 35.94B 290M 260M 240M 218M 407M 27.55B 412M 2.88B 1.14B 14.44B 1.09B 1.07B 45.8B
Net income 2.46B 19.83M 17.79M 16.43M 14.9M 27.85M 1.88B 28.19M 197M 78.24M 987M 74.42M 72.83M 3.13B 2.43B 19.6M 17.6M 16.25M 14.73M 27.54M 1.86B 27.87M 195M 77.36M 976M 73.59M 72.02M 3.1B
Net Debt 22.18B 179M 161M 148M 135M 251M 17.01B 255M 1.78B 706M 8.91B 672M 658M 28.27B 22.87B 185M 166M 153M 139M 259M 17.54B 263M 1.83B 729M 9.19B 693M 678M 29.15B
Projected Income Statement - Annual - The ACME Laboratories Ltd.
Logo The ACME Laboratories Ltd.
The ACME Laboratories Limited is a Bangladesh-based company, which is engaged in manufacturing, marketing, and distribution of pharmaceuticals formulation products. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products, which include human drugs comprising dosages like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, and sachet products. It also offers veterinary drugs comprising dosages like bolus, liquid, injection, water-soluble powder, premix, and herbal drugs comprising dosages like liquid, capsule, tablet, cream, and ointment. The products of the Company are sold in domestic and international markets, respectively. Its factory is situated at Dhulivita, Dhamrai, Dhaka, and Bangladesh. It produces approximately 800 products in different dosage forms.
Employees
9,025
Date Price Change Volume
27/10/26 BDT 77.50 +0.52% 233,599
26/10/26 BDT 77.10 +0.26% 80,142
25/10/26 BDT 76.90 -0.65% 148,480
  1. Stock Market
  2. Stocks
  3. ACMELAB Stock